Showing results (261-270 of 375) with videos related to

Sort By:
Pageof 38
Clinical Nuclear Medicine|April 21, 2025
Insulin Autoimmune Syndrome: Imaging Findings and Uptake Pattern With 68Ga-Exendin-4 and 68Ga-DOTATATE PET-CTRucha Barapatre, Priyanka Verma, Anurag R Lila, et al.
Nuclear Medicine Communications|June 4, 2024
Assessing Krenning's score on 68 Ga-DOTATATE PET-CT and miPSMA score on 68 Ga-PSMA-11 PET-CT in TENIS: a comparison with FDG PET/CT and examining the feasibility of targeted radionuclide therapySunita Sonavane, Omkar Salvi, Ramesh V Asopa, et al.
Clinical Nuclear Medicine|November 24, 2025
False-positive [68Ga]Ga-FAPI-04 PET/CT Following Treatment of 177Lu-DOTATATE PRRT in a Patient With Metastatic High-grade Well-differentiated Neuroendocrine TumorRahul Vithalrao Parghane, Subhash Yadav, Austin Saju, et al.
Nuclear Medicine Communications|July 26, 2019
Metastatic or locally advanced mediastinal neuroendocrine tumours: outcome with 177Lu-DOTATATE-based peptide receptor radionuclide therapy and assessment of prognostic factorsAadil Adnan, Shreyas Kudachi, Sudha Ramesh, et al.
Journal of Nuclear Medicine Technology|July 10, 2021
Correlation of Lesional Uptake Parameters and Ratios with miPSMA Score and Estimating Normal Physiologic Concentration: An Exploratory Analysis in Metastatic Castration-Resistant Prostatic Carcinoma Patients with 68Ga-PSMA-11 PET/CTAshwini Kalshetty, Biju Menon, Sutapa Rakshit, et al.
World Journal of Radiology|January 16, 2013
Potential of (18)F-FDG-PET as a valuable adjunct to clinical and response assessment in rheumatoid arthritis and seronegative spondyloarthropathiesVishu Vijayant, Manjit Sarma, Hrushikesh Aurangabadkar, et al.
Molecular Imaging and Biology|November 15, 2007
Implications of standardized uptake value measurements of the primary lesions in proven cases of breast carcinoma with different degree of disease burden at diagnosis: does 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography predict tumor biology?Sandip Basu, Ayse Mavi, Tevfik Cermik, et al.
The Indian Journal of Chest Diseases & Allied Sciences|August 29, 2018
Potential Clinical Utility of FDG-PET in Non-malignant Pulmonary Disorders: A Pilot StudyMakaresh Yadav, Vinaya S Karkhanis, Sandip Basu, et al.
PET Clinics|June 18, 2022
Molecular Imaging Assessment of Hormonally Sensitive Breast Cancer: An Appraisal of 2-[18F]-Fluoro-2-Deoxy-Glucose and Newer Non-2-[18F]-Fluoro-2-Deoxy-Glucose PET TracersDivya Yadav, Rakesh Kumar, Ankita Phulia, et al.
Expert Opinion on Medical Diagnostics|March 16, 2013
Imaging for the diagnosis of thyroid cancerMuammer Urhan, Murat Velioglu, Joshua Rosenbaum, et al.
Pageof 38